Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2972396 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL151723 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL258358 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL258309 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL258323 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL258329 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL258639 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL2971183 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL3673115 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 | |
| SCHEMBL173701 | 1.00 | KCNH2 (0.46) | KCNH2LIPGNR1H2NR1H3ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 974 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410223-A | Tetraarylethoxy side chain single metallocene compound, catalyst system containing same and polyolefin synthesis method using same | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| WO-2023123884-A1 | TETRAARYL ETHOXY SIDE-CHAIN MONO-METALLOCENE COMPOUND, CATALYST SYSTEM COMPRISING SAME, AND POLYOLEFIN SYNTHESIS METHOD USING SAME | 中国石油天然气股份有限公司 | 2023-07-06 | — | — | WO | claimed |
| CN-116349679-A | Composite disinfection and sterilization method | 孙国明 | 2023-06-30 | — | — | CN | claimed |
| CN-115433376-A | Preparation method of long-acting disinfection and sterilization fabric or fiber | 孙国明 | 2022-12-06 | — | — | CN | claimed |
| CN-112142909-B | Resistance reducing agent and preparation method thereof | 中国石油天然气股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| EP-3784677-A1 | NON-COORDINATING ANION TYPE ACTIVATORS CONTAINING CATION HAVING LARGE ALKYL GROUPS | ExxonMobil Chemical Patents Inc. (US) | 2021-03-03 | — | — | EP | claimed |
| CN-112351987-A | Non-coordinating anionic activators containing cations with large alkyl groups | 埃克森美孚化学专利公司 | 2021-02-09 | — | — | CN | claimed |
| CN-112142909-A | Resistance reducing agent and preparation method thereof | 中国石油天然气股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| US-20190330139-A1 | Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-10-31 | — | — | US | claimed |
| CN-110357902-A | A kind of and five thiophene and its preparation method and application | 哈尔滨工业大学（威海） | 2019-10-22 | — | — | CN | claimed |
| EP-1843409-A2 | Poly(Alkynylthiophene)s and electronic devices generated therefrom | Xerox Corporation (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1843410-A2 | Functionalized heteroacenes and electronic devices generated therefrom | Xerox Corporation (US) | 2007-10-10 | — | — | EP | claimed |
| CN-101050269-A | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORP (US) | 2007-10-10 | — | — | CN | claimed |
| CN-101050267-A | Poly(alkynylthiophene)s and electronic devices generated therefrom | XEROX CORP (US) | 2007-10-10 | — | — | CN | claimed |
| CN-1170879-C | Fire-retardant resin composition and shaped article made of same | ������������ʽ���� | 2004-10-13 | — | — | CN | claimed |
| US-20030099424-A1 | Optical gain media and methods for making and using same | MOHAJER YOUSEF (US) | 2003-05-29 | — | — | US | claimed |
| WO-2003018592-A1 | OPTICAL GAIN MEDIA | PHOTON-X, INC. (US) | 2003-03-06 | — | — | WO | claimed |
| EP-0613059-A1 | Toner | Nippon Paint Co., Ltd. (JP) | 1994-08-31 | — | — | EP | claimed |
| US-5047499-A | Solution polymerization, trimellitic acid derivative and aromatic diamine, multistage, dehydration catalyst | HITACHI CHEMICAL CO., LTD. (JP) | 1991-09-10 | — | — | US | claimed |
| EP-0382864-A1 | Process for the production of high molecular weight polyamide-imide resin | Hitachi Chemical Co., Ltd. (JP) | 1990-08-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330139-A1 | Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups | KCNK10, KCNK4, HCN4 | KCNH2 25/4885LIPG 3676/4885NR1H2 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.